Cannabis Law Report

JULY 19, 2021

RYAH is a recognized leader in dose control technology for plant-based medicine, and we are pleased to be in a position to support the study and establish a new standardization of monitoring and measuring inhalation therapies in plant-based medicines,” said Gabriella Roda, researcher at the Department of Pharmaceuticals at the University of Milan.

Therapy

Cannabis Law Report

SEPTEMBER 10, 2021

is a pioneering Psychedelic Healthcare Innovation & Life Sciences Company in early stage development of Psilocybin (“Magic Mushroom”) based drugs and therapies proudly announces t he Filing of U. HENDERSON, Nev. , Sept. 9, 2021 /PRNewswire/ — PsiloThera, Inc. ” The U.S. .” Source: www.psilothera.com.

Microdosing

Cannabis Law Report

AUGUST 2, 2021

The diversified venture fund is focused on tackling the growing global mental health crisis by investing in innovative psychedelic-based and adjacent therapies that are poised to shape the future of psychiatry and fields beyond. Innovative psychedelic-based and adjacent therapies are poised to shape the future of psychiatry and fields beyond.

Research and Development

Cannabis Law Report

JUNE 30, 2021

In addition, the company aims to predict what treatments are most effective in addressing these conditions, including psychedelics, which have shown tremendous promise in early clinical trials. Even if there’s an accurate diagnosis, many mental health treatments have less-than-desirable efficacy, and there can be significant side effects.

Treatment

SpeedWeed

MARCH 26, 2021

That’s just one step being taken to prepare the state for the eventual implementation of Measure 109, in which 56 percent of voters approved last fall to legalize psychedelic mushroom therapy. . I’m a Black woman and I care about making these treatments relevant to my community,” Hagens said in a press statement. “I

Therapy

Veriheal

OCTOBER 20, 2021

Always consult a physician before attempting psychedelic therapy. Data from a nationally representative sample of participants have been collected since 1975 to understand drug use trends among American young adults, and noteworthy findings are published each fall. Cannabis and magic mushrooms for the win! A Magical Future.

Therapy

Veriheal

MAY 26, 2022

Dedicated to “redefining what’s possible,” the 501(c)(3) organization has provided 1:1 support and resources to over 69,000 clients as they navigated plant-powered cannabinoid therapy. The ORR, an ongoing online survey study, collects self-reported health information to be analyzed by Johns Hopkins for published research papers.

Advocacy

Veriheal

AUGUST 24, 2022

Activists collected over 100,000 more signatures than needed to qualify the measure for the ballot, showing significant support for its passing. In May 2022, Connecticut’s governor signed a budget bill that included a provision for the implementation of psychedelic-assisted therapy treatment centers.

Legalization

NORML

FEBRUARY 8, 2019

Activists in Mississippi have already collected thousands of signatures in hopes of qualifying a medical cannabis ballot initiative for the 2020 ballot. Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed. CT resident? CT resident? OR resident?

Legislation

Canna Care Docs

NOVEMBER 4, 2024

cannabis has been used medicinally as a treatment for pain and other ailments. Today, you can explore personalized treatment plans to aid your distinctive needs. Patients with these conditions frequently seek relief from a variety of traditional treatments. Medicine and orthopedic concept. Since 2727 B.C.

Chronic Pain

Cannabis Law Report

JULY 21, 2021

The treatment is designed to target nociplastic pain originating in the central nervous system through the neuroplasticity benefits of psilocybin. “Existing treatment options for fibromyalgia are often ineffective and show significant side effects,” said Daniel Clauw, M.D.,

Clinical Trials

Veriheal

JUNE 30, 2023

Additionally, participants also reported feeling increased self-awareness and general improvement in relationships following their treatment. Researchers say this emphasizes just how important it is that psilocybin therapy be done in a controlled setting with therapy and community-based after-care.

Clinical Trials

Canna Law Blog

APRIL 13, 2019

These products have not been shown to be safe or effective, and deceptive marketing of unproven treatments may keep some patients from accessing appropriate, recognized therapies to treat serious and even fatal diseases.”. Specifically, the agency fears that.

CBD

Cannabis Law Report

JULY 9, 2021

Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. Psychedelic therapy is not a fringe phenomenon.

Law

The Cannigma

SEPTEMBER 4, 2024

But newer research, including from this year, has indicated that cannabinoid suppositories do have clinical utility, and real-world data collected recently from Cannigma users shows that a CBD product based on a full extract cannabis oil (FECO) can significantly improve menstrual symptoms.

Data

Cannabis Law Report

JULY 28, 2021

Additionally, as previously announced on January 21, 2021, Unifor and Aleafia entered into an exclusive 10-year agreement to support union members, retirees and their eligible dependents that receive medical cannabis insurance coverage clinics through Unifor’s collective bargaining agreements. The recent addition of KGK Science Inc.

Clinical Trials

Cannabis Law Report

AUGUST 3, 2021

Many mental health disorders have treatment options, but they aren’t nearly as safe and efficacious as conventional pharmaceuticals or therapies. The reference data it collects and its constantly improving machine learning algorithms create a moat that prevents competitors from quickly stepping into the market.

Research and Development

Cannabis Law Report

JUNE 23, 2021

Medicann is launching an observational study using RYAH Smart Dry Herb Inhalers in order to collect patient feedback on consumption of cannabis strains available on the Island, including strains supplied by Aurora Europe , a subsidiary of Canadian-headquartered Aurora Cannabis Inc., Forward-Looking Statements.

Programs

Puff Puff Post

MARCH 10, 2020

INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases. With enrollment completed, treatment is expected to conclude towards the end of March and results are anticipated to be announced in the second half of calendar 2020.

Clinical Trials

SpeedWeed

SEPTEMBER 17, 2021

million to assess the efficacy of Multidisciplinary Association for Psychedelic Studies (MAPS) MDMA-assisted therapy to treat traumatic brain injury (TBI). The funding will allow MAPS Public Benefit Corporation (MAPS PBC) to activate a team to evaluate the scope of the lack of resources needed for TBI treatment. .

Clinical Trials

The Joint Blog

APRIL 25, 2019

“We also sought to collect data on other pertinent outcomes related to the use of cannabis to enhance understanding of the potential benefits this complementary therapy offers.”

Therapy

Cannabis Law Report

JULY 7, 2021

is a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments. It is working to provide the critical infrastructure needed to develop and deliver breakthrough mental health treatments. KetamineOne Capital Limited (formerly Myconic Capital Corp.) On behalf of: KETAMINE ONE.

Research and Development

Cannabis Law Report

DECEMBER 11, 2021

This reduction in prices will make the clinic the cheapest option for many patients looking to receive medical cannabis treatments for a wide variety of conditions and illnesses. Medical cannabis can be considered as a treatment for a number of conditions – including chronic pain, epilepsy, and insomnia – when first-line options have failed.

Access

Cannabis Law Report

SEPTEMBER 28, 2021

The results of this survey cannot be shared with you, as the survey does not collect any contact details or personal information. Privacy Notice: In collecting your personal information within this research, the ANU must comply with the Privacy Act 1988. My ANIP host organisation (Johnathan Davis MLA’s office) may also use the data.

Therapy

Cannabis Law Report

AUGUST 21, 2019

Cannabis treatments are too expensive and do not come with enough test evidence to be effective, UK authorities have said. It also said current treatments for adults suffering severe symptoms were “not cost effective”. The watchdog said a network of children’s doctors should be created to collect evidence and advice on difficult cases.

Clinical Trials

Cannabis Law Report

MARCH 3, 2020

Now, he is the Vice-Chair of Indiana NORML — an organization who is currently focused on changing cannabis laws for the access to Medical Cannabis as therapeutic treatment in Indiana. The goal is to develop an evidence-based approach to its use in the treatment of disease and symptom management. . ” CANNABINOID BACKGROUND: .

Policy

Cannabis Law Report

NOVEMBER 3, 2021

This collectively brings the Company’s total clinic count to 15 globally. Khiron in the United Kingdom The company is pursuing a consistent approach to improve patient access to medical cannabis and to develop the market for medical cannabis treatments in the UK.

Therapy

Cannabis Law Report

DECEMBER 9, 2021

The study involved 100 treatment-resistant patients and were randomized to psilocybin or the nicotine patch, each receiving the same cognitive-behavioral therapy. At 12 months, 59% of the patients who received the psilocybin treatment remained abstinent, while only 28% of those who received the nicotine patch remained abstinent.

Clinical Trials

The Joint Blog

FEBRUARY 24, 2021

They made it clear that no evidence is available and that there are real potential risks to treatment. On surveying medical professionals it was found that most had been asked about cannabis-based alternative treatment by their patients. had described some form of significant benefit from the treatment.

Treatment

Cannabis Law Report

MAY 29, 2022

TORONTO , May 27, 2022 /CNW/ – 12 companies from across the country joined forces today to found Psychedelics Canada , the first, national-level trade association representing the blossoming psychedelic medicine and therapy industry. Psychedelics Canada Launch Press conference. . ” ABOUT PSYCHEDELICS CANADA.

Research and Development

Canna Care Docs

SEPTEMBER 18, 2020

To prepare for your appointment you will want to collect your medical records about the condition you wish to treat with medical cannabis. A medical provider may recommend medical cannabis to treat any condition that they feel may benefit from medical cannabis and cannabinoid-based therapies. History of Medical Marijuana in Virginia.

Pharmaceutical

LifeCannMD

JANUARY 31, 2025

For many families, particularly in communities where extended family ties run deep, HD becomes part of their collective narrative – a shared challenge that spans generations. These cultural dimensions aren’t footnotes in treatment they’re essential chapters in each family’s story.

Conditions

Cannabis Law Report

JANUARY 12, 2022

According to a recent report released by the Psychedelic Science Funders Collaborative, “Oregon’s psilocybin therapy program provides a high-quality model for psychedelic healing in a non-prescription context that could be replicated in other states.” ABOUT THE NATIONAL PSYCHEDELICS ASSOCIATION.

Research and Development

CannaTech

SEPTEMBER 23, 2019

This bottleneck has left patients and parents to pursue unregulated avenues to access treatment. NICE develop evidence-based guidelines on a wide range of health-related topics, including integrating novel and emerging therapies. It is tragic that in the UK, cannabis is denied to the most vulnerable citizens.

Patients

Miss Marijuana

JUNE 7, 2019

CBD treatments and therapies are working their way into these different areas of health and wellness: · Cancer. · Digestion. · Mental Health. · Untreatable Diseases. Currently, research is finding CBD oil to be a complementary therapy for cancer symptoms, like pain and nausea. CBD can help support you too!

Oil

Cannabis Law Report

OCTOBER 5, 2021

M oney has begun flowing into companies intending to monetize psychedelic therapy as new research has increasingly shown that blowing one’s mind can alter it for the better,” reads an article in The Los Angeles Times titled “Money is pouring into psychedelics. For Consortium News. Caitlin isn’t far off the mark.

Therapy

Cannabis Law Report

DECEMBER 1, 2021

Join Chacruna and mental health experts and activists, Allison Feduccia, PhD, Vilmarie Fraguada Narloch, PsyD, Kylea Taylor, MS, LMFT, and Emma Knighton, MA, LMHC, to discuss topics around standards of care and accountability for practitioners in the psychedelic-therapy space, addressing issues of power, hierarchy, and abuse.

Safety